Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionMAb against insulin-like growth factor-1 (IGF-1) and insulin-like growth factor-2 (IGF-2)
Molecular Target Insulin-like growth factor-1 (IGF-1) ; Insulin-like growth factor-2 (IGF-2)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today